Frélii, Inc. (FRLI)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Frélii, Inc. (FRLI) with AI Score 51/100 (Hold). Frélii, Inc. specializes in personalized nutrition and wellness programs delivered through its online platform. Market cap: 0, Sector: Technology.
Last analyzed: Mar 17, 2026Frélii, Inc. (FRLI) Technology Profile & Competitive Position
Frélii, Inc. provides personalized, subscription-based nutrition and wellness programs, leveraging genetic data and lifestyle factors to tailor health plans. Operating within the application software sector, the company offers a platform for health assessments, nutritional guidance, and related products, targeting consumers seeking customized wellness solutions.
Investment Thesis
Frélii, Inc. presents a unique investment opportunity within the personalized nutrition and wellness space. The company's focus on leveraging genetic data and lifestyle factors to create customized health plans offers a differentiated approach in a growing market. With a gross margin of 22.5%, there's potential for profitability as the company scales its subscription-based model. Key value drivers include expanding its user base through targeted marketing and partnerships, increasing subscription revenue, and introducing new product offerings such as advanced diagnostic kits and personalized supplements. However, potential investors should be aware of the risks associated with the company's OTC listing, including limited liquidity and disclosure. Furthermore, the company's negative profit margin of -15439.4% indicates significant challenges in achieving profitability. The company's high beta of 3.42 suggests high volatility. Success hinges on effective execution of its growth strategies and navigating the competitive landscape.
Based on FMP financials and quantitative analysis
Key Highlights
- Frélii, Inc. operates in the personalized nutrition and wellness market, offering customized health plans based on genetic data and lifestyle factors.
- The company's platform, frelii.com, provides health assessments, nutrition plans, lab diagnostic kits, and nutritional supplements.
- Frélii, Inc. was rebranded from Vican Resources, Inc. in March 2018, signaling a strategic shift towards personalized wellness.
- The company's gross margin stands at 22.5%, indicating potential for profitability with increased scale and operational efficiency.
- Frélii, Inc. has a market capitalization of $0.00B, highlighting its early-stage growth potential and associated risks.
Competitors & Peers
Strengths
- Personalized nutrition plans based on genetic data.
- Subscription-based revenue model.
- Online platform for program delivery and product sales.
- Offers lab diagnostic kits and compounding pharmacy products.
Weaknesses
- Limited market capitalization ($0.00B).
- Negative profit margin (-15439.4%).
- OTC listing with limited liquidity and disclosure.
- Small number of employees (10).
Catalysts
- Upcoming: Potential partnerships with healthcare providers or fitness centers could expand market reach.
- Upcoming: Launch of a mobile app to enhance user engagement and data collection.
- Ongoing: Expansion of product offerings, such as advanced diagnostic kits and personalized supplements.
- Ongoing: Increasing consumer awareness of personalized nutrition and wellness.
- Ongoing: Leveraging AI and machine learning to improve the accuracy of personalized nutrition plans.
Risks
- Potential: Limited liquidity due to OTC Other listing may hinder trading activity.
- Potential: Negative profit margin (-15439.4%) raises concerns about financial sustainability.
- Ongoing: Competition from larger nutrition and supplement companies could erode market share.
- Potential: Changing regulations in the health and wellness industry may impact business operations.
- Potential: Data privacy and security breaches could damage reputation and erode customer trust.
Growth Opportunities
- Expansion of Product Offerings: Frélii can expand its product line to include more advanced and specialized diagnostic kits. The market for genetic testing and personalized diagnostics is growing rapidly, with a projected market size of $13.8 billion by 2027. By offering a wider range of diagnostic tools, Frélii can attract new customers and increase revenue per user. This initiative can be implemented within the next 12-18 months, requiring investment in research and development and partnerships with diagnostic labs.
- Strategic Partnerships: Collaborating with healthcare providers, fitness centers, and corporate wellness programs can significantly expand Frélii's reach and customer base. The corporate wellness market is a multi-billion dollar industry, with companies increasingly investing in employee health programs. By partnering with these organizations, Frélii can offer its personalized nutrition plans as part of a comprehensive wellness package. These partnerships can be established within the next 6-12 months, requiring a dedicated sales and marketing effort.
- International Market Expansion: Frélii can explore opportunities to expand its services to international markets, particularly in regions with a growing interest in personalized health and wellness. The global wellness market is expanding rapidly, with significant growth potential in Asia-Pacific and Europe. Adapting its platform and services to meet the specific needs and regulations of different countries can open up new revenue streams. This expansion can be phased in over the next 2-3 years, starting with pilot programs in select markets.
- Development of a Mobile App: Creating a user-friendly mobile app can enhance customer engagement and provide a more convenient way for users to access their personalized nutrition plans and track their progress. Mobile health apps are becoming increasingly popular, with millions of users worldwide. An app can also enable Frélii to collect more data on user behavior and preferences, further improving the personalization of its services. The app can be developed and launched within the next 9-12 months, requiring investment in software development and user interface design.
- Leveraging AI and Machine Learning: Implementing AI and machine learning technologies can enhance the accuracy and effectiveness of Frélii's personalized nutrition plans. AI can be used to analyze large datasets of genetic and lifestyle information to identify patterns and predict individual responses to different dietary interventions. This can lead to more precise and effective recommendations, improving customer satisfaction and retention. AI integration can be implemented in phases over the next 12-24 months, requiring investment in data science expertise and AI infrastructure.
Opportunities
- Expansion of product offerings (e.g., advanced diagnostic kits).
- Strategic partnerships with healthcare providers and fitness centers.
- International market expansion.
- Development of a mobile app.
Threats
- Competition from larger nutrition and supplement companies.
- Changing regulations in the health and wellness industry.
- Potential data privacy and security breaches.
- Economic downturn affecting consumer spending on wellness products.
Competitive Advantages
- Proprietary algorithms for personalized nutrition plan creation.
- Access to genetic data and personalized health information.
- Subscription-based revenue model providing recurring income.
- Established online platform (frelii.com) for program delivery and product sales.
About FRLI
Frélii, Inc., formerly known as Vican Resources, Inc. until its rebranding in March 2018, operates in the technology sector, specifically within the application software industry. The company is headquartered in Lehi, Utah, and focuses on delivering personalized nutrition and wellness programs through its frelii.com web platform. Frélii's core offering revolves around creating customized health assessments and nutrition plans, taking into account a range of factors including genetic data, individual physiology, environmental influences, and lifestyle choices. These plans are designed to provide users with tailored guidance on diet, exercise, and overall well-being. In addition to its personalized plans, Frélii also provides a suite of related products and services. These include lab diagnostic kits that allow users to gather relevant health data, compounding pharmacy products tailored to individual needs, and a range of nutritional and vitamin supplements designed to support the personalized nutrition plans. The company's business model is centered around subscription-based access to its platform and the sale of these related products. Frélii's competitive positioning is centered around its ability to offer a highly personalized approach to nutrition and wellness, differentiating itself from more generic wellness programs and supplement providers. The company aims to leverage technology and data to provide a more effective and tailored experience for its users.
What They Do
- Provide personalized nutrition and wellness programs.
- Offer health assessments based on genetic data and lifestyle factors.
- Create customized nutrition plans tailored to individual needs.
- Provide access to lab diagnostic kits for health data collection.
- Offer compounding pharmacy products.
- Sell nutritional and vitamin supplements.
- Operate an online platform (frelii.com) for program delivery and product sales.
Business Model
- Subscription-based access to personalized nutrition and wellness programs.
- Revenue from the sale of lab diagnostic kits.
- Sales of compounding pharmacy products.
- Sales of nutritional and vitamin supplements.
Industry Context
Frélii, Inc. operates within the rapidly expanding personalized nutrition and wellness market. This market is driven by increasing consumer awareness of the link between diet, lifestyle, and health outcomes. The global wellness market is estimated to be worth trillions of dollars, with personalized nutrition representing a significant growth segment. Competitors range from large nutrition and supplement companies to smaller, specialized firms offering genetic testing and personalized health plans. Frélii's success depends on its ability to differentiate itself through its technology platform, data-driven approach, and personalized customer experience. The company faces competition from companies like ANVV (Anavex Life Sciences Corp.), CGLO (Cogilo Technologies Corp.), EDTA (Edita Food Industries S.A.E.), GEMSF (GEMS Science Fund I, Inc.), and GOLQ (Gold Lion Holding Inc.).
Key Customers
- Individuals seeking personalized nutrition and wellness solutions.
- Health-conscious consumers interested in genetic-based health plans.
- Customers looking for customized vitamin and supplement regimens.
- Users of the frelii.com web platform.
Financials
Chart & Info
Frélii, Inc. (FRLI) stock price: Price data unavailable
Latest News
-
Stocks That Hit 52-Week Lows On Thursday
· Oct 10, 2019
-
Stocks That Hit 52-Week Lows On Wednesday
· Oct 9, 2019
-
Stocks That Hit 52-Week Lows On Tuesday
· Oct 8, 2019
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for FRLI.
Price Targets
Wall Street price target analysis for FRLI.
MoonshotScore
What does this score mean?
The MoonshotScore rates FRLI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Ian Geran Jenkins
CEO
Ian Geran Jenkins serves as the CEO of Frélii, Inc. His background includes experience in managing small teams and guiding companies through periods of transition, as evidenced by his leadership at Frélii, which employs 10 individuals. While specific details regarding his prior roles and educational background are not available, his current position indicates a focus on strategic direction and operational oversight within the personalized nutrition and wellness sector.
Track Record: As CEO of Frélii, Ian Geran Jenkins has overseen the company's focus on personalized nutrition and wellness programs. Specific milestones and achievements under his leadership are not detailed in the provided information. His tenure is marked by the company's efforts to establish a presence in the competitive market of personalized health solutions.
FRLI OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Frélii, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited operating history, are undergoing financial distress, or may not be current in their reporting obligations. Investing in companies on the OTC Other tier carries significant risks due to the potential for fraud, lack of transparency, and limited liquidity compared to companies listed on major exchanges like the NYSE or NASDAQ. These stocks are often referred to as 'penny stocks'.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity due to OTC Other listing.
- Lack of transparency and disclosure.
- Potential for fraud and manipulation.
- High price volatility.
- Uncertain financial viability.
- Verify the company's financial statements and reporting status.
- Research the background and experience of the management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's cash flow and ability to fund operations.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal issues.
- Company has a registered business address in Lehi, Utah.
- Company has been in operation since at least 2018 (rebranding from Vican Resources).
- Company has a functional website (frelii.com).
- Company offers a specific product/service (personalized nutrition plans).
- CEO is identified (Ian Geran Jenkins).
Frélii, Inc. Stock: Key Questions Answered
What does Frélii, Inc. do?
Frélii, Inc. is a technology company operating in the personalized nutrition and wellness sector. The company provides customized health assessments and nutrition plans based on individual genetic data, physiology, environmental factors, and lifestyle choices. These plans are delivered through its online platform, frelii.com, which also offers lab diagnostic kits, compounding pharmacy products, and nutritional supplements. Frélii's business model centers around subscription-based access to its platform and the sale of related health and wellness products, targeting consumers seeking tailored solutions for their health needs.
What do analysts say about FRLI stock?
There is currently no available analyst coverage or consensus on Frélii, Inc. (FRLI) stock. Given its OTC Other listing and limited market capitalization, the company is not widely followed by analysts. Investors should conduct their own thorough research and due diligence before considering an investment in FRLI. Key valuation metrics, such as price-to-earnings ratio and price-to-sales ratio, are either not meaningful or unavailable due to the company's negative profitability and limited financial disclosure. Growth considerations should focus on the company's ability to expand its user base, increase subscription revenue, and achieve profitability.
What are the main risks for FRLI?
The main risks for Frélii, Inc. include its OTC Other listing, which implies limited liquidity and disclosure, increasing the potential for volatility and manipulation. The company's negative profit margin (-15439.4%) raises concerns about its financial sustainability and ability to fund future growth. Competition from larger, more established nutrition and supplement companies poses a significant threat to its market share. Furthermore, changing regulations in the health and wellness industry, as well as potential data privacy and security breaches, could negatively impact its business operations and reputation. Investors should carefully consider these risks before investing in FRLI.
What are the key factors to evaluate for FRLI?
Frélii, Inc. (FRLI) currently holds an AI score of 51/100, indicating moderate score. Key strength: Personalized nutrition plans based on genetic data.. Primary risk to monitor: Potential: Limited liquidity due to OTC Other listing may hinder trading activity.. This is not financial advice.
How frequently does FRLI data refresh on this page?
FRLI prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven FRLI's recent stock price performance?
Recent price movement in Frélii, Inc. (FRLI) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Personalized nutrition plans based on genetic data.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider FRLI overvalued or undervalued right now?
Determining whether Frélii, Inc. (FRLI) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying FRLI?
Before investing in Frélii, Inc. (FRLI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial information available due to OTC Other listing.
- Lack of analyst coverage.